With regard to the transfers of medicines from the extramural framework to the intramural framework, the precondition is that the effects are monitored. The immunoglobulins and Gaucher drugs will be transferred as of 1.1.2021 and the CSF drugs and epoetins as of 1.1.2022. A zero measurement must be made for immunoglobulins in 2020. The effect measurement will take place in 2021/2022. For the epoetins and CSF agents, the option should include the option for a baseline measurement in 2021 and an effect measurement in 2022/2023. The client expects a report of every measurement.

Note: the Gaucher medicines are being transferred, but the monitoring thereof is not covered by this assignment. In the quotation we ask for a modular structure per drug group.

The costs for the research over a 5-year period are estimated at a total amount between EUR 200,000 and EUR 300,000.